{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:40:26Z","timestamp":1794948026508,"version":"4.9.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    RelA, also known as nuclear factor kappa B p65, plays a crucial role in the pathogenesis of various liver diseases. However, the specific role of RelA in hepatocytes during the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) is not well understood. This study explored the relationship between impaired RelA signaling and lipid metabolism disorders in hepatocytes, and how they synergistically contribute to the advancement of MASLD. We assessed the changes, regulatory relationships, and impacts of RelA signaling and lipid metabolism remodeling on disease progression both in vitro and in vivo. During MASLD, there was a decrease in the expression of RelA and hepatocyte nuclear factor 1 alpha (HNF1\u03b1), with both factors showing mutual enhancement of each other\u2019s expression under normal conditions. This synergistic effect was absent during hepatocyte steatosis. RelA or HNF1\u03b1 depletion in hepatocytes intensified MASLD symptoms, whereas overexpression of\n                    <jats:italic>RELA<\/jats:italic>\n                    or treatment with necrostatin-1 (a necroptosis inhibitor) or Z-VAD (a caspase inhibitor) significantly mitigated these effects. Mechanistically, during hepatic steatosis, altered lipid profiles exhibited lipotoxicity, inducing hepatocyte apoptosis and necroptosis, whereas endoplasmic reticulum (ER) stress triggered lipid remodeling processes similar to those observed in MASLD. RelA signaling upregulated the expression of activating transcription factor 4 and glucose-regulated protein 78, thereby alleviating ER stress. Impaired RelA signaling remodeled the ER stress response and lipid metabolism, and enhanced lipid accumulation and lipid toxicity. In conclusion, impaired RelA signaling and disrupted lipid metabolism form a detrimental feedback loop in hepatocytes that promotes MASLD progression. Lipid accumulation suppresses RelA signaling, remodeling the ER stress response and exacerbating lipid metabolism disorder, ultimately leading to hepatocyte apoptosis and necroptosis.\n                  <\/jats:p>","DOI":"10.1038\/s41420-025-02312-3","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T17:58:45Z","timestamp":1738778325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Impaired RelA signaling and lipid metabolism dysregulation in hepatocytes: driving forces in the progression of metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Yihuai","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikedaimu","family":"Abudukeremu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuerbiye","family":"Nuermaimaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5729-9889","authenticated-orcid":false,"given":"Yaqun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"2312_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1053\/j.gastro.2023.11.007","volume":"166","author":"AM Allen","year":"2024","unstructured":"Allen AM, Pose E, Reddy KR, Russo MW, Kamath PS. Nonalcoholic fatty liver disease gets renamed as metabolic dysfunction-associated steatotic liver disease: progress but with challenges. Gastroenterology. 2024;166:229\u201334.","journal-title":"Gastroenterology"},{"key":"2312_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","volume":"55","author":"J Ludwig","year":"1980","unstructured":"Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434\u20138.","journal-title":"Mayo Clin Proc"},{"key":"2312_CR3","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J, International Consensus P. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158:1999\u20132014.e1991.","journal-title":"Gastroenterology"},{"key":"2312_CR4","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","volume":"107","author":"KE Chan","year":"2022","unstructured":"Chan KE, Koh TJL, Tang ASP, Quek J, Yong JN, Tay P, et al. Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals. J Clin Endocrinol Metab. 2022;107:2691\u20132700.","journal-title":"J Clin Endocrinol Metab"},{"key":"2312_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.cgh.2021.11.038","volume":"21","author":"GEH Lim","year":"2023","unstructured":"Lim GEH, Tang A, Ng CH, Chin YH, Lim WH, Tan DJH, et al. An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD. Clin Gastroenterol Hepatol. 2023;21:619\u2013629.e617.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2312_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:739\u201352.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2312_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","volume":"122","author":"V Lekakis","year":"2024","unstructured":"Lekakis V, Papatheodoridis GV. Natural history of metabolic dysfunction-associated steatotic liver disease. Eur J Intern Med. 2024;122:3\u201310.","journal-title":"Eur J Intern Med"},{"key":"2312_CR8","first-page":"939","volume":"9","author":"T Prasoppokakorn","year":"2021","unstructured":"Prasoppokakorn T, Pitisuttithum P, Treeprasertsuk S. Pharmacological therapeutics: current trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). J Clin Transl Hepatol. 2021;9:939\u201346.","journal-title":"J Clin Transl Hepatol"},{"key":"2312_CR9","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1042\/CS20220572","volume":"136","author":"OO Badmus","year":"2022","unstructured":"Badmus OO, Hillhouse SA, Anderson CD, Hinds TD, Stec DE. Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways. Clin Sci. 2022;136:1347\u201366.","journal-title":"Clin Sci"},{"key":"2312_CR10","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.3748\/wjg.v24.i25.2661","volume":"24","author":"T Kanda","year":"2018","unstructured":"Kanda T, Matsuoka S, Yamazaki M, Shibata T, Nirei K, Takahashi H, et al. Apoptosis and non-alcoholic fatty liver diseases. World J Gastroenterol. 2018;24:2661\u201372.","journal-title":"World J Gastroenterol"},{"key":"2312_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06161-9","volume":"14","author":"MP Scavo","year":"2023","unstructured":"Scavo MP, Negro R, Arre V, Depalo N, Carrieri L, Rizzi F, et al. The oleic\/palmitic acid imbalance in exosomes isolated from NAFLD patients induces necroptosis of liver cells via the elongase-6\/RIP-1 pathway. Cell Death Dis. 2023;14:635.","journal-title":"Cell Death Dis"},{"key":"2312_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature14191","volume":"517","author":"M Pasparakis","year":"2015","unstructured":"Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature. 2015;517:311\u201320.","journal-title":"Nature"},{"key":"2312_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05615-4","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang S, Chang N, Li W, Yang T, Xue R, Liu J, et al. Necroptosis of macrophage is a key pathological feature in biliary atresia via GDCA\/S1PR2\/ZBP1\/p-MLKL axis. Cell Death Dis. 2023;14:175.","journal-title":"Cell Death Dis"},{"key":"2312_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrc.2017.96","volume":"18","author":"B Ogretmen","year":"2018","unstructured":"Ogretmen B. Sphingolipid metabolism in cancer signalling and therapy. Nat Rev Cancer. 2018;18:33\u201350.","journal-title":"Nat Rev Cancer"},{"key":"2312_CR15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/cells9030627","volume":"9","author":"X Zhang","year":"2020","unstructured":"Zhang X, Matsuda M, Yaegashi N, Nabe T, Kitatani K. Regulation of necroptosis by phospholipids and sphingolipids. Cells. 2020;9:627.","journal-title":"Cells"},{"key":"2312_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/biomedicines10010127","volume":"10","author":"A Adameova","year":"2022","unstructured":"Adameova A, Horvath C, Abdul-Ghani S, Varga ZV, Suleiman MS, Dhalla NS. Interplay of oxidative stress and necrosis-like cell death in cardiac ischemia\/reperfusion injury: a focus on necroptosis. Biomedicines. 2022;10:127.","journal-title":"Biomedicines"},{"key":"2312_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.133","volume":"8","author":"F Basit","year":"2017","unstructured":"Basit F, van Oppen LM, Schockel L, Bossenbroek HM, van Emst-de Vries SE, Hermeling JC, et al. Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells. Cell Death Dis. 2017;8:e2716.","journal-title":"Cell Death Dis"},{"key":"2312_CR18","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1080\/15548627.2021.2002109","volume":"18","author":"J Lou","year":"2022","unstructured":"Lou J, Wang X, Zhang H, Yu G, Ding J, Zhu X, et al. Inhibition of PLA2G4E\/cPLA2 promotes survival of random skin flaps by alleviating Lysosomal membrane permeabilization-Induced necroptosis. Autophagy. 2022;18:1841\u201363.","journal-title":"Autophagy"},{"key":"2312_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/ijms22010066","volume":"22","author":"C Xue","year":"2020","unstructured":"Xue C, Gu X, Li G, Bao Z, Li L. Mitochondrial mechanisms of necroptosis in liver diseases. Int J Mol Sci. 2020;22:66.","journal-title":"Int J Mol Sci"},{"key":"2312_CR20","doi-asserted-by":"publisher","first-page":"106598","DOI":"10.1016\/j.biocel.2024.106598","volume":"172","author":"P Kettel","year":"2024","unstructured":"Kettel P, Karagoz GE. Endoplasmic reticulum: monitoring and maintaining protein and membrane homeostasis in the endoplasmic reticulum by the unfolded protein response. Int J Biochem Cell Biol. 2024;172:106598.","journal-title":"Int J Biochem Cell Biol"},{"key":"2312_CR21","doi-asserted-by":"publisher","first-page":"6412916","DOI":"10.1155\/2020\/6412916","volume":"2020","author":"Y Zou","year":"2020","unstructured":"Zou Y, Qi Z. Understanding the role of exercise in nonalcoholic fatty liver disease: ERS-linked molecular pathways. Mediators Inflamm. 2020;2020:6412916.","journal-title":"Mediators Inflamm"},{"key":"2312_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02786-6","volume":"19","author":"S Xia","year":"2021","unstructured":"Xia S, Duan W, Liu W, Zhang X, Wang Q. GRP78 in lung cancer. J Transl Med. 2021;19:118.","journal-title":"J Transl Med"},{"key":"2312_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05444-x","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Guo J, Yang N, Huang Y, Hu T, Rao C. Endoplasmic reticulum stress-mediated cell death in liver injury. Cell Death Dis. 2022;13:1051.","journal-title":"Cell Death Dis"},{"key":"2312_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ceb.2020.04.002","volume":"65","author":"BP Phillips","year":"2020","unstructured":"Phillips BP, Gomez-Navarro N, Miller EA. Protein quality control in the endoplasmic reticulum. Curr Opin Cell Biol. 2020;65:96\u2013102.","journal-title":"Curr Opin Cell Biol"},{"key":"2312_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1196\/annals.1299.032","volume":"1010","author":"E Szegezdi","year":"2003","unstructured":"Szegezdi E, Fitzgerald U, Samali A. Caspase-12 and ER-stress-mediated apoptosis: the story so far. Ann NY Acad Sci. 2003;1010:186\u201394.","journal-title":"Ann NY Acad Sci"},{"key":"2312_CR26","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/14728222.2022.2170780","volume":"26","author":"Y Luo","year":"2022","unstructured":"Luo Y, Jiao Q, Chen Y. Targeting endoplasmic reticulum stress-the responder to lipotoxicity and modulator of non-alcoholic fatty liver diseases. Expert Opin Ther Targets. 2022;26:1073\u201385.","journal-title":"Expert Opin Ther Targets"},{"key":"2312_CR27","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","volume":"69","author":"C Lebeaupin","year":"2018","unstructured":"Lebeaupin C, Vallee D, Hazari Y, Hetz C, Chevet E, Bailly-Maitre B. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2018;69:927\u201347.","journal-title":"J Hepatol"},{"key":"2312_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41757-x","volume":"14","author":"W Wang","year":"2023","unstructured":"Wang W, Tan J, Liu X, Guo W, Li M, Liu X, et al. Cytoplasmic Endonuclease G promotes nonalcoholic fatty liver disease via mTORC2-AKT-ACLY and endoplasmic reticulum stress. Nat Commun. 2023;14:6201.","journal-title":"Nat Commun"},{"key":"2312_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","volume":"152","author":"Z Chen","year":"2020","unstructured":"Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med. 2020;152:116\u201341.","journal-title":"Free Radic Biol Med"},{"key":"2312_CR30","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301158RR","volume":"38","author":"Q Chen","year":"2024","unstructured":"Chen Q, Li L, Samidurai A, Thompson J, Hu Y, Willard B, et al. Acute endoplasmic reticulum stress-induced mitochondria respiratory chain damage: the role of activated calpains. FASEB J. 2024;38:e23404.","journal-title":"FASEB J"},{"key":"2312_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z, Zhang H, Hu H. Targeting NF-kappaB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther. 2020;5:209.","journal-title":"Signal Transduct Target Ther"},{"key":"2312_CR32","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/ncb2324","volume":"13","author":"C Mauro","year":"2011","unstructured":"Mauro C, Leow SC, Anso E, Rocha S, Thotakura AK, Tornatore L, et al. NF-kappaB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nat Cell Biol. 2011;13:1272\u20139.","journal-title":"Nat Cell Biol"},{"key":"2312_CR33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jhep.2015.08.033","volume":"64","author":"UA Kohler","year":"2016","unstructured":"Kohler UA, Bohm F, Rolfs F, Egger M, Hornemann T, Pasparakis M, et al. NF-kappaB\/RelA and Nrf2 cooperate to maintain hepatocyte integrity and to prevent development of hepatocellular adenoma. J Hepatol. 2016;64:94\u2013102.","journal-title":"J Hepatol"},{"key":"2312_CR34","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1053\/j.gastro.2009.02.081","volume":"136","author":"F Oakley","year":"2009","unstructured":"Oakley F, Teoh V, Ching ASG, Bataller R, Colmenero J, Jonsson JR, et al. Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. Gastroenterology. 2009;136:2334\u20132344.e2331.","journal-title":"Gastroenterology"},{"key":"2312_CR35","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1038\/onc.2015.526","volume":"35","author":"A Moles","year":"2016","unstructured":"Moles A, Butterworth JA, Sanchez A, Hunter JE, Leslie J, Sellier H, et al. A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-kappaB-dependent liver regeneration and cancer. Oncogene. 2016;35:4623\u201332.","journal-title":"Oncogene"},{"key":"2312_CR36","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1053\/j.gastro.2007.03.033","volume":"132","author":"F Geisler","year":"2007","unstructured":"Geisler F, Algul H, Paxian S, Schmid RM. Genetic inactivation of RelA\/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro. Gastroenterology. 2007;132:2489\u2013503.","journal-title":"Gastroenterology"},{"key":"2312_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15846-8","volume":"12","author":"SY Liu","year":"2022","unstructured":"Liu SY, Rao JX, Deng J, Zhang GJ, Jiang XL, Cheng J, et al. Feedback loop between hepatocyte nuclear factor 1alpha and endoplasmic reticulum stress mitigates liver injury by downregulating hepatocyte apoptosis. Sci Rep. 2022;12:11602.","journal-title":"Sci Rep"},{"key":"2312_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/1874467212666190930144349","volume":"13","author":"S Begum","year":"2020","unstructured":"Begum S. Hepatic nuclear factor 1 alpha (HNF-1alpha) in human physiology and molecular medicine. Curr Mol Pharmacol. 2020;13:50\u201356.","journal-title":"Curr Mol Pharmacol"},{"key":"2312_CR39","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1681\/ASN.V11suppl_2s140","volume":"11","author":"M Pontoglio","year":"2000","unstructured":"Pontoglio M. Hepatocyte nuclear factor 1, a transcription factor at the crossroads of glucose homeostasis. J Am Soc Nephrol. 2000;11:S140\u2013143.","journal-title":"J Am Soc Nephrol"},{"key":"2312_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108018","volume":"26","author":"M Liu","year":"2023","unstructured":"Liu M, Liu L, Guo H, Fan X, Liu T, Xu C, et al. Dominant-negative HNF1alpha mutant promotes liver steatosis and inflammation by regulating hepatic complement factor D. iScience. 2023;26:108018.","journal-title":"iScience"},{"key":"2312_CR41","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/1873-3468.12689","volume":"591","author":"Q Ni","year":"2017","unstructured":"Ni Q, Ding K, Wang KQ, He J, Yin C, Shi J, et al. Deletion of HNF1alpha in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice. FEBS Lett. 2017;591:1947\u201357.","journal-title":"FEBS Lett"},{"key":"2312_CR42","doi-asserted-by":"publisher","first-page":"8883","DOI":"10.3390\/ijms23168883","volume":"23","author":"E Sucajtys-Szulc","year":"2022","unstructured":"Sucajtys-Szulc E, Debska-Slizien A, Rutkowski B, Szolkiewicz M, Swierczynski J, Smolenski RT. Hepatocyte nuclear factor 1alpha proinflammatory effect linked to the overexpression of liver nuclear factor-kappaB in experimental model of chronic kidney disease. Int J Mol Sci. 2022;23:8883.","journal-title":"Int J Mol Sci"},{"key":"2312_CR43","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1371\/journal.pgen.0010023","volume":"1","author":"RJ Tolwani","year":"2005","unstructured":"Tolwani RJ, Hamm DA, Tian L, Sharer JD, Vockley J, Rinaldo P, et al. Medium-chain acyl-CoA dehydrogenase deficiency in gene-targeted mice. PLoS Genet. 2005;1:e23.","journal-title":"PLoS Genet"},{"key":"2312_CR44","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/S0022-2275(20)32437-8","volume":"40","author":"UJ Tietge","year":"1999","unstructured":"Tietge UJ, Bakillah A, Maugeais C, Tsukamoto K, Hussain M, Rader DJ. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J Lipid Res. 1999;40:2134\u20139.","journal-title":"J Lipid Res"},{"key":"2312_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1053\/jhep.2003.50309","volume":"38","author":"P Letteron","year":"2003","unstructured":"Letteron P, Sutton A, Mansouri A, Fromenty B, Pessayre D. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology. 2003;38:133\u201340.","journal-title":"Hepatology"},{"key":"2312_CR46","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1016\/j.celrep.2020.01.108","volume":"30","author":"KA Ngo","year":"2020","unstructured":"Ngo KA, Kishimoto K, Davis-Turak J, Pimplaskar A, Cheng Z, Spreafico R, et al. Dissecting the regulatory strategies of NF-kappaB RelA target genes in the inflammatory response reveals differential transactivation logics. Cell Rep. 2020;30:2758\u20132775.e2756.","journal-title":"Cell Rep"},{"key":"2312_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27452-9","volume":"12","author":"F Yao","year":"2021","unstructured":"Yao F, Deng Y, Zhao Y, Mei Y, Zhang Y, Liu X, et al. A targetable LIFR-NF-kappaB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis. Nat Commun. 2021;12:7333.","journal-title":"Nat Commun"},{"key":"2312_CR48","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1172\/JCI59408","volume":"122","author":"LJ Quinton","year":"2012","unstructured":"Quinton LJ, Blahna MT, Jones MR, Allen E, Ferrari JD, Hilliard KL, et al. Hepatocyte-specific mutation of both NF-kappaB RelA and STAT3 abrogates the acute phase response in mice. J Clin Investig. 2012;122:1758\u201363.","journal-title":"J Clin Investig"},{"key":"2312_CR49","doi-asserted-by":"publisher","first-page":"e00132","DOI":"10.1128\/IAI.00132-19","volume":"87","author":"Y Kim","year":"2019","unstructured":"Kim Y, Allen E, Baird LA, Symer EM, Korkmaz FT, Na E, et al. NF-kappaB RelA is required for hepatoprotection during pneumonia and sepsis. Infect Immun. 2019;87:e00132\u201300119.","journal-title":"Infect Immun"},{"key":"2312_CR50","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1194\/jlr.M025130","volume":"53","author":"K Dai","year":"2012","unstructured":"Dai K, Hussain MM. NR2F1 disrupts synergistic activation of the MTTP gene transcription by HNF-4alpha and HNF-1alpha. J Lipid Res. 2012;53:901\u20138.","journal-title":"J Lipid Res"},{"key":"2312_CR51","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/S0006-2952(03)00586-0","volume":"66","author":"C Cheung","year":"2003","unstructured":"Cheung C, Akiyama TE, Kudo G, Gonzalez FJ. Hepatic expression of cytochrome P450s in hepatocyte nuclear factor 1-alpha (HNF1alpha)-deficient mice. Biochem Pharmacol. 2003;66:2011\u201320.","journal-title":"Biochem Pharmacol"},{"key":"2312_CR52","doi-asserted-by":"publisher","first-page":"27117","DOI":"10.1016\/S0021-9258(19)61487-0","volume":"275","author":"TE Akiyama","year":"2000","unstructured":"Akiyama TE, Ward JM, Gonzalez FJ. Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1alpha (HNF1alpha). Alterations in fatty acid homeostasis in HNF1alpha-deficient mice. J Biol Chem. 2000;275:27117\u201322.","journal-title":"J Biol Chem"},{"key":"2312_CR53","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1111\/liv.15607","volume":"43","author":"S Yang","year":"2023","unstructured":"Yang S, Xu B, Han Y, Jiang M, Luo T, Wu N, et al. TAF15 exacerbates nonalcoholic steatohepatitis progression by regulating lipid metabolism and inflammation via FASN and p65 NF-kappaB. Liver Int. 2023;43:1920\u201336.","journal-title":"Liver Int"},{"key":"2312_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcmgh.2022.03.006","volume":"14","author":"X Huang","year":"2022","unstructured":"Huang X, Yao Y, Hou X, Wei L, Rao Y, Su Y, et al. Macrophage SCAP contributes to metaflammation and lean NAFLD by activating STING-NF-kappaB signaling pathway. Cell Mol Gastroenterol Hepatol. 2022;14:1\u201326.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2312_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","volume":"15","author":"Y Geng","year":"2021","unstructured":"Geng Y, Faber KN, de Meijer VE, Blokzijl H, Moshage H. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Hepatol Int. 2021;15:21\u201335.","journal-title":"Hepatol Int"},{"key":"2312_CR56","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","volume":"81","author":"H Yoon","year":"2021","unstructured":"Yoon H, Shaw JL, Haigis MC, Greka A. Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity. Mol Cell. 2021;81:3708\u201330.","journal-title":"Mol Cell"},{"key":"2312_CR57","doi-asserted-by":"publisher","first-page":"G75","DOI":"10.1152\/ajpgi.00170.2018","volume":"316","author":"S Liangpunsakul","year":"2019","unstructured":"Liangpunsakul S, Chalasani N. Lipid mediators of liver injury in nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol. 2019;316:G75\u2013G81.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2312_CR58","doi-asserted-by":"publisher","first-page":"RP88084","DOI":"10.7554\/eLife.88084.3","volume":"12","author":"M Brischigliaro","year":"2023","unstructured":"Brischigliaro M, Cabrera-Orefice A, Arnold S, Viscomi C, Zeviani M, Fernandez-Vizarra E. Structural rather than catalytic role for mitochondrial respiratory chain supercomplexes. Elife. 2023;12:RP88084.","journal-title":"Elife"},{"key":"2312_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","volume":"52","author":"AP Rolo","year":"2012","unstructured":"Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med. 2012;52:59\u201369.","journal-title":"Free Radic Biol Med"},{"key":"2312_CR60","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.tem.2012.04.005","volume":"23","author":"M Pagadala","year":"2012","unstructured":"Pagadala M, Kasumov T, McCullough AJ, Zein NN, Kirwan JP. Role of ceramides in nonalcoholic fatty liver disease. Trends Endocrinol Metab. 2012;23:365\u201371.","journal-title":"Trends Endocrinol Metab"},{"key":"2312_CR61","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.biochi.2013.07.027","volume":"100","author":"A Kogot-Levin","year":"2014","unstructured":"Kogot-Levin A, Saada A. Ceramide and the mitochondrial respiratory chain. Biochimie. 2014;100:88\u201394.","journal-title":"Biochimie"},{"key":"2312_CR62","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-230X-9-53","volume":"9","author":"I Treede","year":"2009","unstructured":"Treede I, Braun A, Jeliaskova P, Giese T, Fullekrug J, Griffiths G, et al. TNF-alpha-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells. BMC Gastroenterol. 2009;9:53.","journal-title":"BMC Gastroenterol"},{"key":"2312_CR63","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/eji.201040899","volume":"41","author":"JM van Dieren","year":"2011","unstructured":"van Dieren JM, Simons-Oosterhuis Y, Raatgeep HC, Lindenbergh-Kortleve DJ, Lambers ME, van der Woude CJ, et al. Anti-inflammatory actions of phosphatidylinositol. Eur J Immunol. 2011;41:1047\u201357.","journal-title":"Eur J Immunol"},{"key":"2312_CR64","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/icb.2016.125","volume":"95","author":"EJ Petrie","year":"2017","unstructured":"Petrie EJ, Hildebrand JM, Murphy JM. Insane in the membrane: a structural perspective of MLKL function in necroptosis. Immunol Cell Biol. 2017;95:152\u20139.","journal-title":"Immunol Cell Biol"},{"key":"2312_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2020.111579","volume":"208","author":"Y Yang","year":"2021","unstructured":"Yang Y, Xu G, Xu Y, Cheng X, Xu S, Chen S, et al. Ceramide mediates radiation-induced germ cell apoptosis via regulating mitochondria function and MAPK factors in Caenorhabditis elegans. Ecotoxicol Environ Saf. 2021;208:111579.","journal-title":"Ecotoxicol Environ Saf"},{"key":"2312_CR66","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1194\/jlr.R067595","volume":"57","author":"J Han","year":"2016","unstructured":"Han J, Kaufman RJ. The role of ER stress in lipid metabolism and lipotoxicity. J Lipid Res. 2016;57:1329\u201338.","journal-title":"J Lipid Res"},{"key":"2312_CR67","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12944-020-01210-0","volume":"19","author":"J Wang","year":"2020","unstructured":"Wang J, He W, Tsai PJ, Chen PH, Ye M, Guo J, et al. Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease. Lipids Health Dis. 2020;19:72.","journal-title":"Lipids Health Dis"},{"key":"2312_CR68","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3748\/wjg.v30.i9.1189","volume":"30","author":"JL Jiang","year":"2024","unstructured":"Jiang JL, Zhou YY, Zhong WW, Luo LY, Liu SY, Xie XY, et al. Uridine diphosphate glucuronosyltransferase 1A1 prevents the progression of liver injury. World J Gastroenterol. 2024;30:1189\u2013212.","journal-title":"World J Gastroenterol"},{"key":"2312_CR69","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","volume":"54","author":"H Malhi","year":"2011","unstructured":"Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol. 2011;54:795\u2013809.","journal-title":"J Hepatol"},{"key":"2312_CR70","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/s42255-022-00631-8","volume":"4","author":"Y Chen","year":"2022","unstructured":"Chen Y, Wu Z, Huang S, Wang X, He S, Liu L, et al. Adipocyte IRE1alpha promotes PGC1alpha mRNA decay and restrains adaptive thermogenesis. Nat Metab. 2022;4:1166\u201384.","journal-title":"Nat Metab"},{"key":"2312_CR71","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.tibs.2018.06.005","volume":"43","author":"J Hwang","year":"2018","unstructured":"Hwang J, Qi L. Quality control in the endoplasmic reticulum: crosstalk between ERAD and UPR pathways. Trends Biochem Sci. 2018;43:593\u2013605.","journal-title":"Trends Biochem Sci"},{"key":"2312_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2020.114535","volume":"263","author":"J Qin","year":"2020","unstructured":"Qin J, Ru S, Wang W, Hao L, Ru Y, Wang J, et al. Long-term bisphenol S exposure aggravates non-alcoholic fatty liver by regulating lipid metabolism and inducing endoplasmic reticulum stress response with activation of unfolded protein response in male zebrafish. Environ Pollut. 2020;263:114535.","journal-title":"Environ Pollut"},{"key":"2312_CR73","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jhep.2021.01.042","volume":"75","author":"C Liu","year":"2021","unstructured":"Liu C, Zhou B, Meng M, Zhao W, Wang D, Yuan Y, et al. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease. J Hepatol. 2021;75:150\u201362.","journal-title":"J Hepatol"},{"key":"2312_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05738-8","volume":"14","author":"J Cai","year":"2023","unstructured":"Cai J, Ye Z, Hu Y, Ye L, Gao L, Wang Y, et al. Fatostatin induces ferroptosis through inhibition of the AKT\/mTORC1\/GPX4 signaling pathway in glioblastoma. Cell Death Dis. 2023;14:211.","journal-title":"Cell Death Dis"},{"key":"2312_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03762-0","volume":"12","author":"X Ma","year":"2021","unstructured":"Ma X, Zhao T, Yan H, Guo K, Liu Z, Wei L, et al. Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-kappaB pathway in endometrial carcinoma. Cell Death Dis. 2021;12:544.","journal-title":"Cell Death Dis"},{"key":"2312_CR76","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/hep.24396","volume":"54","author":"A Cinaroglu","year":"2011","unstructured":"Cinaroglu A, Gao C, Imrie D, Sadler KC. Activating transcription factor 6 plays protective and pathological roles in steatosis due to endoplasmic reticulum stress in zebrafish. Hepatology. 2011;54:495\u2013508.","journal-title":"Hepatology"},{"key":"2312_CR77","doi-asserted-by":"publisher","first-page":"30142","DOI":"10.1074\/jbc.M115.676239","volume":"290","author":"S Olivares","year":"2015","unstructured":"Olivares S, Henkel AS. Hepatic Xbp1 gene deletion promotes endoplasmic reticulum stress-induced liver injury and apoptosis. J Biol Chem. 2015;290:30142\u201351.","journal-title":"J Biol Chem"},{"key":"2312_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101991","volume":"8","author":"J Lin","year":"2021","unstructured":"Lin J, Jiang X, Dong M, Liu X, Shen Q, Huang Y, et al. Hepatokine pregnancy zone protein governs the diet-induced thermogenesis through activating brown adipose tissue. Adv Sci. 2021;8:e2101991.","journal-title":"Adv Sci"},{"key":"2312_CR79","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1038\/onc.2013.437","volume":"33","author":"WT Chen","year":"2014","unstructured":"Chen WT, Zhu G, Pfaffenbach K, Kanel G, Stiles B, Lee AS. GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN. Oncogene. 2014;33:4997\u20135005.","journal-title":"Oncogene"},{"key":"2312_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03264-5","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Li X, Liu D, Zhang S, Tan N, Yokota H, et al. Phosphorylation of eIF2alpha signaling pathway attenuates obesity-induced non-alcoholic fatty liver disease in an ER stress and autophagy-dependent manner. Cell Death Dis. 2020;11:1069.","journal-title":"Cell Death Dis"},{"key":"2312_CR81","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.2337\/db09-0335","volume":"58","author":"J Seo","year":"2009","unstructured":"Seo J, Fortuno ES 3rd, Suh JM, Stenesen D, Tang W, Parks EJ, et al. Atf4 regulates obesity, glucose homeostasis, and energy expenditure. Diabetes. 2009;58:2565\u201373.","journal-title":"Diabetes"},{"key":"2312_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16587-9","volume":"7","author":"KY Yeh","year":"2017","unstructured":"Yeh KY, Lai CY, Lin CY, Hsu CC, Lo CP, Her GM. ATF4 overexpression induces early onset of hyperlipidaemia and hepatic steatosis and enhances adipogenesis in zebrafish. Sci Rep. 2017;7:16362.","journal-title":"Sci Rep"},{"key":"2312_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06091-7","volume":"9","author":"J Wei","year":"2018","unstructured":"Wei J, Yuan Y, Chen L, Xu Y, Zhang Y, Wang Y, et al. ER-associated ubiquitin ligase HRD1 programs liver metabolism by targeting multiple metabolic enzymes. Nat Commun. 2018;9:3659.","journal-title":"Nat Commun"},{"key":"2312_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154349","volume":"114","author":"K Li","year":"2021","unstructured":"Li K, Zhang K, Wang H, Wu Y, Chen N, Chen J, et al. Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db\/db mice. Metabolism. 2021;114:154349.","journal-title":"Metabolism"},{"key":"2312_CR85","doi-asserted-by":"publisher","first-page":"1370012","DOI":"10.3389\/fcell.2024.1370012","volume":"12","author":"D Wu","year":"2024","unstructured":"Wu D, Liang J. Activating transcription factor 4: a regulator of stress response in human cancers. Front Cell Dev Biol. 2024;12:1370012.","journal-title":"Front Cell Dev Biol"},{"key":"2312_CR86","doi-asserted-by":"publisher","first-page":"C224","DOI":"10.1152\/ajpcell.00080.2023","volume":"325","author":"JM Memme","year":"2023","unstructured":"Memme JM, Sanfrancesco VC, Hood DA. Activating transcription factor 4 regulates mitochondrial content, morphology, and function in differentiating skeletal muscle myotubes. Am J Physiol Cell Physiol. 2023;325:C224\u2013C242.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2312_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93663-1","volume":"11","author":"NI Lorenz","year":"2021","unstructured":"Lorenz NI, Sittig ACM, Urban H, Luger AL, Engel AL, Munch C, et al. Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide. Sci Rep. 2021;11:14161.","journal-title":"Sci Rep"},{"key":"2312_CR88","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.3390\/ijms18081710","volume":"18","author":"B Feng","year":"2017","unstructured":"Feng B, Huang X, Jiang D, Hua L, Zhuo Y, Wu D. Endoplasmic reticulum stress inducer tunicamycin alters hepatic energy homeostasis in mice. Int J Mol Sci. 2017;18:1710.","journal-title":"Int J Mol Sci"},{"key":"2312_CR89","doi-asserted-by":"publisher","first-page":"57","DOI":"10.7754\/Clin.Lab.2015.150521","volume":"62","author":"B Glibert","year":"2016","unstructured":"Glibert B, Bourleaux V, Peeters R, Reynolds T, Vranken G. Analytical performance verification of the Beckman Coulter AU5800 clinical chemistry analyser against recognized quality specifications reveals relevance of method harmonization. Clin Lab. 2016;62:57\u201372.","journal-title":"Clin Lab"},{"key":"2312_CR90","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.3748\/wjg.v28.i26.3201","volume":"28","author":"YF Chen","year":"2022","unstructured":"Chen YF, Liu SY, Cheng QJ, Wang YJ, Chen S, Zhou YY, et al. Intracellular alpha-fetoprotein mitigates hepatocyte apoptosis and necroptosis by inhibiting endoplasmic reticulum stress. World J Gastroenterol. 2022;28:3201\u201317.","journal-title":"World J Gastroenterol"},{"key":"2312_CR91","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev A, Hitomi J, Germscheid M, Ch\u2019en IL, Korkina O, Teng X, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008;4:313\u201321.","journal-title":"Nat Chem Biol"},{"key":"2312_CR92","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.neuroscience.2017.12.007","volume":"371","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhang L, Yu H, Song K, Shi J, Chen L, et al. Necrostatin-1 improves long-term functional recovery through protecting oligodendrocyte precursor cells after transient focal cerebral ischemia in mice. Neuroscience. 2018;371:229\u201341.","journal-title":"Neuroscience"},{"key":"2312_CR93","doi-asserted-by":"publisher","first-page":"30993","DOI":"10.1074\/jbc.M303763200","volume":"278","author":"R Ilangovan","year":"2003","unstructured":"Ilangovan R, Marshall WL, Hua Y, Zhou J. Inhibition of apoptosis by Z-VAD-fmk in SMN-depleted S2 cells. J Biol Chem. 2003;278:30993\u20139.","journal-title":"J Biol Chem"},{"key":"2312_CR94","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40104-021-00668-x","volume":"13","author":"K Qiu","year":"2022","unstructured":"Qiu K, Wang Y, Xu D, He L, Zhang X, Yan E, et al. Ryanodine receptor RyR1-mediated elevation of Ca(2+) concentration is required for the late stage of myogenic differentiation and fusion. J Anim Sci Biotechnol. 2022;13:9.","journal-title":"J Anim Sci Biotechnol"},{"key":"2312_CR95","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1210\/en.2018-00093","volume":"159","author":"R Van Krieken","year":"2018","unstructured":"Van Krieken R, Marway M, Parthasarathy P, Mehta N, Ingram AJ, Gao B, et al. Inhibition of SREBP with fatostatin does not attenuate early diabetic nephropathy in male mice. Endocrinology. 2018;159:1479\u201395.","journal-title":"Endocrinology"},{"key":"2312_CR96","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.redox.2018.06.010","volume":"18","author":"X Cai","year":"2018","unstructured":"Cai X, Liu Y, Hu Y, Liu X, Jiang H, Yang S, et al. ROS-mediated lysosomal membrane permeabilization is involved in bupivacaine-induced death of rabbit intervertebral disc cells. Redox Biol. 2018;18:65\u201376.","journal-title":"Redox Biol"},{"key":"2312_CR97","doi-asserted-by":"publisher","first-page":"983","DOI":"10.4149\/neo_2021_210205N180","volume":"68","author":"H Chen","year":"2021","unstructured":"Chen H, Chen GM, Liu YJ, Rao JX, Zhou SZ, Chen S, et al. Alpha-fetoprotein\/endoplasmic reticulum stress signaling mitigates injury in hepatoma cells. Neoplasma. 2021;68:983\u201393.","journal-title":"Neoplasma"},{"key":"2312_CR98","doi-asserted-by":"publisher","first-page":"100933","DOI":"10.1016\/j.jbc.2021.100933","volume":"297","author":"B Guo","year":"2021","unstructured":"Guo B, Shi X, Ma Z, Ji M, Tang C, Wang F. A ratiometric dual luciferase reporter for quantitative monitoring of pre-mRNA splicing efficiency in vivo. J Biol Chem. 2021;297:100933.","journal-title":"J Biol Chem"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02312-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02312-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02312-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:49:44Z","timestamp":1738781384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02312-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2312"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02312-3","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"3 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experimental protocol was approved by the Zunyi Medical University Medical Ethics Review Committee, application numbers ZMER [2023]1-172 for cell experiments, and ZMU21-2107-003 and ZMU22-2303-029 for animal experiments. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"49"}}